<DOC>
	<DOC>NCT01577446</DOC>
	<brief_summary>Current recommendations require a QRS duration of â‰¥120ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure of ischemic origin, current indications for defibrillator implantation and QRS &lt;120ms may benefit from CRT in the presence of marked mechanical dyssynchrony.</brief_summary>
	<brief_title>Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure, Systolic</mesh_term>
	<criteria>NHYA class IIIII heart failure ischemic cardiomyopathy ejection fraction of 35% or less QRS interval of 120ms or less evidence of mechanical dyssynchrony as measured on echocardiography conventional indication for cardiac pacing persistent atrial fibrillation life expectancy lower than 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>CRT</keyword>
	<keyword>heart failure</keyword>
	<keyword>narrow QRS</keyword>
	<keyword>dyssynchrony</keyword>
</DOC>